{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/new-era-clinical-trial-how-immuno-oncology-advances-are-reshaping-traditional-clinical-0#webpage",
"url": "https://www.fortrea.com/insights/new-era-clinical-trial-how-immuno-oncology-advances-are-reshaping-traditional-clinical-0",
"name": "A new era of the clinical trial: How immuno-oncology advances are reshaping traditional clinical development paradigms",
"description": "Explore this Fortrea white paper on reshaping traditional clinical development paradigms through innovative oncology trial design, basket trials, umbrella trial models, and adaptive clinical development strategies. The white paper examines modern precision oncology approaches including biomarker-driven trial design, master protocol frameworks, platform trial strategies, decentralized clinical trial models, patient-centric research approaches, and operational flexibility designed to improve clinical trial efficiency and accelerate oncology drug development. It also highlights challenges associated with traditional oncology development paradigms while outlining integrated strategies that support optimized trial execution, patient enrollment and retention, regulatory alignment, precision medicine initiatives, and faster delivery of targeted oncology therapies across increasingly complex clinical development programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "A new era of the clinical trial: How immuno-oncology advances are reshaping traditional clinical development paradigms",
"item": "https://www.fortrea.com/insights/new-era-clinical-trial-how-immuno-oncology-advances-are-reshaping-traditional-clinical-0"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/new-era-clinical-trial-how-immuno-oncology-advances-are-reshaping-traditional-clinical-0#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/new-era-clinical-trial-how-immuno-oncology-advances-are-reshaping-traditional-clinical-0#webpage"
},
"headline": "Oncology Trial Design Beyond Traditional Clinical Development Paradigms | Fortrea White Paper",
"description": "Explore this Fortrea white paper on reshaping traditional clinical development paradigms through innovative oncology trial design, basket trials, umbrella trial models, and adaptive clinical development strategies. The white paper examines modern precision oncology approaches including biomarker-driven trial design, master protocol frameworks, platform trial strategies, decentralized clinical trial models, patient-centric research approaches, and operational flexibility designed to improve clinical trial efficiency and accelerate oncology drug development. It also highlights challenges associated with traditional oncology development paradigms while outlining integrated strategies that support optimized trial execution, patient enrollment and retention, regulatory alignment, precision medicine initiatives, and faster delivery of targeted oncology therapies across increasingly complex clinical development programs.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-03/reshaping-traditional-clinical-development-paradigms.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-17",
"dateModified": "2025-03-17",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-03/reshaping-traditional-clinical-development-paradigms.pdf",
"encodingFormat": "application/pdf"
}
}
]
}